Cellectricon Overview

  • Status
  • Private
  • Employees
  • 20
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 4

Cellectricon General Information


Operator of a medical technology platform designed to offer advanced cell-based screening services. The company's platform is ideal for compound profiling in excitable primary cells and native tissue, which creates complex disease models and assays for functional and morphological screening, enabling researchers to identify phenotypic effects in highly relevant biological models early enough in a project's lifecycle.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • Neongatan 4B
  • 431 53 Mölndal
  • Sweden
+46 031-760 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellectricon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 000.00 Completed Generating Revenue
4. Grant 30-Sep-2006 00000 000.00 Completed Generating Revenue
3. Early Stage VC (Series B) 26-May-2004 00.000 000.00 Completed Startup
2. Early Stage VC 24-Jun-2002 $4.67M $6.79M Completed Startup
1. Seed Round 01-Jan-2000 $2.12M $2.12M Completed Startup
To view Cellectricon’s complete valuation and funding history, request access »

Cellectricon Executive Team (6)

Name Title Board Seat Contact Info
Mattias Karlsson Ph.D Founder, Chief Executive Officer, Chief Technology Officer & Vice President of Science & Technology
Kristina Hillskär Chief Financial Officer
Johan Pihl Ph.D Chief Operating Officer
Paul Karila Ph.D Chief Scientific Officer & Director
You’re viewing 4 of 6 executive team members. Get the full list »

Cellectricon Board Members (6)

Name Representing Role Since
Axel Broms Self Board Member 000 0000
David Burns Self Board Member 000 0000
Erik Kullgren Dunross & Co Board Member 000 0000
Jan-Olof Lundin Self Chairman 000 0000
Jörgen Persson Dunross & Co Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Cellectricon Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cellectricon Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Vinnova Government Minority 000 0000 000000 0
Dunross & Co PE/Buyout Minority 000 0000 000000 0
Karolinska Investment Fund Venture Capital Minority 000 0000 000000 0
Patricia Industries PE/Buyout Minority 000 0000 000000 0
To view Cellectricon’s complete investors history, request access »